Emerging pathogens are an increasing threat because most treatments for them are failing.
Read More about WBB Securities will be sponsoring a Demy-Colton Virtual Salon (webinar) on May 17, 2023
Paraphrasing a line miscredited to Einstein: “Insanity is repeating the same mistakes and expecting different results.”
Read More about Healthier Uses For The $5 Billion NextGen Covid-19 FundsSix months ago, I wrote in Forbes how the Fed’s Inflation fight would harm Biotech. With the FDIC takeover of Silicon Valley Bank (SVB) using the receiver, Deposit Insurance National Bank of Santa Clara the judgment has proven to be correct.
Read More about The 5 SVB Critical Questions And Answers For BiotechFor Immediate Release February 20, 2023 Cranford, NJ– Steve Brozak, DMH, President of WBB Securities today participated in a Biotech Showcase session titled, Capital Preservation: How to Preserve Capital and Retain Control of Your Research. It […]
Read More about Steve Brozak, President of WBB Securities Participated in the 2023 Biotech Showcase Session Titled, Capital Preservation: How to Preserve Capital and Retain Control of Your ResearchA looming and avoidable Covid-19 crisis is on the horizon as detailed by Dr. Steve Brozak in a piece breaking today for Forbes. The pandemic emergency declaration is to end May 11 with only “placeholder” healthcare directors in charge.
Read More about The Next Covid-19 Crisis, May 11th And Our Missing Healthcare LeadershipWBBRI assembled a panel of experts, including its own Director of Medical Research, Dr. Richard A. Marfuggi, to explain not only the physiologic processes of Covid/sepsis but also the critical importance of deployment and adoption of rapid diagnostics and targeted therapeutics
Read More about Meeting the Challenges of Sepsis in Severe Coronavirus Disease 2019: A Call to Arms